Mark Meltz

Mark Meltz

Conseiller Juridique Général chez LYELL IMMUNOPHARMA, INC.
52 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mark Adam Meltz is Secretary & General Counsel at Lyell Immunopharma, Inc. since 2025.
Formerly, Mr. Meltz was COO, Secretary, Treasurer & General Counsel at Kinnate Biopharma, Inc. from 2020 to 2024; Senior Vice President & General Counsel at Astellas Gene Therapies, Inc. from 2019 to 2020; Chief Business Development & Legal Officer at Emergent Travel Health, Inc. from 2014 to 2019; Associate General Counsel at Biogen, Inc. from 2007 to 2012; Counsel at BMC Partners LLP; and Head-North & Latin America Legal Division at Novartis Vaccines & Diagnostics, Inc. Education includes undergraduate studies at Yale University and graduate studies at Boston College Law School.

Postes actifs de Mark Meltz

SociétésPosteDébut
LYELL IMMUNOPHARMA, INC. Conseiller Juridique Général 09/06/2025

Anciens postes connus de Mark Meltz

SociétésPosteFin
KINNATE BIOPHARMA INC. Directeur Financier/CFO 07/06/2021
AUDENTES THERAPEUTICS, INC. Conseiller Juridique Général 01/02/2020
Conseiller Juridique Général 01/03/2019
BIOGEN INC. Conseiller Juridique Général 01/03/2012
Corporate Officer/Principal -
Voir l'expérience en détail de Mark Meltz

Formation de Mark Meltz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Meltz